Matsumae, T.; Kodama, T.; Myojin, Y.; Maesaka, K.; Sakamori, R.; Takuwa, A.; Oku, K.; Motooka, D.; Sawai, Y.; Oshita, M.;
et al. Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy. Cancers 2022, 14, 3367.
https://doi.org/10.3390/cancers14143367
AMA Style
Matsumae T, Kodama T, Myojin Y, Maesaka K, Sakamori R, Takuwa A, Oku K, Motooka D, Sawai Y, Oshita M,
et al. Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy. Cancers. 2022; 14(14):3367.
https://doi.org/10.3390/cancers14143367
Chicago/Turabian Style
Matsumae, Takayuki, Takahiro Kodama, Yuta Myojin, Kazuki Maesaka, Ryotaro Sakamori, Ayako Takuwa, Keiko Oku, Daisuke Motooka, Yoshiyuki Sawai, Masahide Oshita,
and et al. 2022. "Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy" Cancers 14, no. 14: 3367.
https://doi.org/10.3390/cancers14143367
APA Style
Matsumae, T., Kodama, T., Myojin, Y., Maesaka, K., Sakamori, R., Takuwa, A., Oku, K., Motooka, D., Sawai, Y., Oshita, M., Nakabori, T., Ohkawa, K., Miyazaki, M., Tanaka, S., Mita, E., Tawara, S., Yakushijin, T., Nozaki, Y., Hagiwara, H.,
... Takehara, T.
(2022). Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy. Cancers, 14(14), 3367.
https://doi.org/10.3390/cancers14143367